Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Halidou Tinto visited the Jenner Institute and gave a seminar on the international partnerships for health research in Africa. He told the story of how he created the first clinical research facility in Burkina Faso. The renowned Clinical Research Unit of Nanoro plays a crucial role in the fight against malaria and his team led the phase I/IIb clinical trial for the R21/Matrix-M malaria vaccine developed at the Jenner Institute.

Professor Tinto's inspirational talk focussed on his scientific journey from the creation of CRUN as the first clinical research facility in Burkina Faso, to the important role played by the unit in the fight against malaria in recent years. His team led the phase I/IIb clinical trial for R21/Matrix-M and was part of the phase III clinical trials of both R21/Matrix-M and RTSS, along with other African collaborators.

Prof Tinto also spoke about the need for African research institutions to direct their own research agenda and how important it is to maintain a critical mass of expertise within countries. Over lunch, he discussed what role early career researchers at the Jenner Institute can play in this process. Here’s to many more collaborations with talented African scientists taking the lead!